Rare diseases
Investigational molecules
Locations
Back to Germany23 clinical trials in Böblingen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on multiple sclerosis treatments, including studies comparing new therapies like fenebrutinib and frexalimab with established treatments. Several trials are investigating novel approaches for both relapsing and primary progressive forms of MS.
Additional studies explore innovative treatments for migraine prevention in patients who haven't responded to conventional therapies.
Comprehensive research into major depressive disorder and schizophrenia, evaluating new therapeutic approaches. Trials include testing novel compounds for depression with anhedonia and long-term safety studies for schizophrenia treatments.
Studies also examine new formulations for ADHD treatment in adults, comparing immediate and modified-release medications.
Innovative trials in breast cancer treatment, particularly focusing on HER2-negative and triple-negative variants. Studies evaluate both neoadjuvant and adjuvant therapeutic approaches.
Additional research examines treatment strategies for locally advanced rectal cancer, comparing pre- and post-surgical interventions.
Critical research into Alzheimer's disease and related conditions, with studies focusing on treating associated symptoms like psychosis and agitation in dementia patients.
These trials aim to improve quality of life for patients with neurodegenerative disorders through targeted symptom management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
